Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2022 | 2014
Number of items: 3.

2022

Bethge, Wolfgang A., Martus, Peter, Schmitt, Michael, Holtick, Udo, Subklewe, Marion, von Tresckow, Bastian ORCID: 0000-0003-1410-4487, Ayuk, Francis, Wagner-Drouet, Eva Marie, Wulf, Gerald G., Marks, Reinhard, Penack, Olaf, Schnetzke, Ulf, Koenecke, Christian, von Bonin, Malte ORCID: 0000-0002-2995-3230, Stelljes, Matthias, Glass, Bertram, Baldus, Claudia D., Vucinic, Vladan ORCID: 0000-0002-8398-285X, Mougiakakos, Dimitrios, Topp, Max, Fante, Matthias A., Schroers, Roland, Bayir, Lale, Borchmann, Peter, Buecklein, Veit, Hasenkamp, Justin, Hanoun, Christine, Thomas, Simone, Beelen, Dietrich W., Lengerke, Claudia, Kroeger, Nicolaus and Dreger, Peter (2022). GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany. Blood, 140 (4). S. 349 - 359. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2014

Kornblit, Brian, Maloney, David G., Storer, Barry E., Maris, Michael B., Vindelov, Lars, Hari, Parameswaran ORCID: 0000-0002-8800-297X, Langston, Amelia A., Pulsipher, Michael A., Bethge, Wolfgang A., Chauncey, Thomas R., Lange, Thoralf, Petersen, Finn B., Huebel, Kai, Woolfrey, Ann E., Flowers, Mary E. D., Storb, Rainer and Sandmaier, Brenda M. (2014). A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation. Haematologica, 99 (10). S. 1624 - 1632. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Kroeger, Nicolaus, Brand, Ronald, Niederwieser, Dietger, Platzbecker, Uwe, Huebel, Kai, Weber, Thomas, Robin, Marie, Stelljes, Matthias, Afanasiev, Boris V., Heim, Dominik, Deliliers, Giorgio Lambertenghi, Onida, Francesco, Dreger, Peter, Pini, Massimo, Guidi, Stefano, Volin, Liisa, Gramatzki, Martin, Bethge, Wolfgang A., Poire, Xavier, Kobbe, Guido, van Os, Marleen, Iacobelli, Simona and de Witte, Theo (2014). Reduced Intensity Vs. Standard Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with MDS or Secondary AML: A Prospective, Randomized Phase III Study of the Chronic Malignancies Working Party of the EBMT (RICMAC-Trial). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

This list was generated on Sun Nov 24 07:09:41 2024 CET.